Skip to main
IVVD

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc. is strategically positioned within a lucrative market, as evidenced by the substantial $56 billion revenue generated by mRNA COVID-19 vaccines in 2022, indicating a strong demand for innovative antiviral solutions. The company’s development of VYD2311, which has received FDA support for its Phase 3 program, presents a significant opportunity to capture a larger target market and demonstrate the potential superiority of monoclonal antibodies over existing mRNA vaccines. Additionally, the incorporation of half-life extension technology in VYD2311, coupled with favorable biophysical characteristics, establishes a pathway for Invivyd to achieve best-in-class status and tap into a projected global market valued at $3-4 billion by 2030.

Bears say

Invivyd Inc. faces considerable challenges due to the misleading results from its in silico modeling, which revealed a 200-fold decrease in the efficacy of its antibody candidates against the omicron variant during the STAMP trial. Additionally, the effectiveness of mRNA vaccines, relevant to Invivyd's market, is declining, particularly among vulnerable populations such as the elderly and immunocompromised, further shrinking the commercially viable opportunity for the company’s products. Compounded by diminishing COVID-19 vaccination rates and growing vaccine hesitancy, the overall market opportunity for Invivyd's antibody-based solutions appears significantly reduced, impacting the company's financial outlook.

Invivyd Inc (IVVD) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Jan 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.